Clinical Trials Search Results 1 - 8 of 8 Results AML - Expanded Access Study of Gilteritinib (ASP2215) in Patients With FMS-like Tyrosine Kinase 3 (FLT3) Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) or FLT3-Mutated AML in Complete Remission (CR) With Minimal Residual Disease (MRD) Read More DLBCL Relapsed - A Study of Obinutuzumab, Polatuzumab Vedotin, and Venetoclax in Relapsed or Refractory Follicular Lymphoma (FL) or Diffuse Large B-Cell Lymphoma (DLBCL) Evaluates the safety, efficacy, and pharmacokinetics of induction treatment with obinutuzumab, polatuzumab vedotin, and venetoclax in participants with relapsed or refractory FL or DLBCL. Read More All cancers - Study of LOXO-101 in Subjects With NTRK Fusion Positive Solid Tumors (NAVIGATE) Read More All Cancers - Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma Read More All cancers VTE - Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer Read More All cancers - An Open Label Phase 2 Multicohort Trial of Nivolumab in Advanced or Metastatic Malignancies Read More MDS - Efficacy and Safety of FG-4592 for Treatment of Anemia in Patients With Lower Risk MDS With Low Red Blood Cell Transfusion Burden Read More Multiple Myeloma Relapsed - Study of Combinations of Nivolumab, Elotuzumab, Pomalidomide and Dexamethasone in Multiple Myeloma Read More 1 - 8 of 8 Results